Before he died, my Dad told me, “Son, twenty years from now, you’ll be more disappointed by the things you didn’t do, than by the things you did. So throw off the bowlines, catch the wind and sail away from the safe harbour”.
I’ve never forgotten his mantra. I grew up in an entrepreneurial household, with a clever Mum and a father I’ve competed against my whole life.
I began working in the technology industry when I was 23 with a full head of hair, working for Burroughs earning $9,000 a year. That summer, I drove to work in the company car – a Datsun Bluebird – with all the windows down.
Artrya is the kind of AI startup I dreamt of creating.
My co-founder John Konstantopoulos and I began with the seed of an idea: that there must be some way to stop so many people dying of heart disease, the world’s biggest killer.
In two-and-a-half years, Artrya has developed a novel approach to the detection and reporting of coronary artery disease. We have grown into a $100m company with leading technology that can rewrite the medical history books.
Artrya wants to save lives using Artificial Intelligence – the seed bank of future medical technologies – while creating economic value for shareholders.
What’s more, our home is in Perth, Western Australia. Our team of thirty-five people are world class clinicians, data scientists, research analysts and medical industry professionals.
We want to make Perth a world-leading centre for medical technology. We want Western Australia to reap the rewards of an AI startup capable of changing the landscape of heart disease.
The future has landed.
John Barrington
CO-FOUNDER AND MANAGING DIRECTOR